FDA Inspection 1254712 — Istituto Biochimico Italiano Giovanni Lorenzini S.p.A.

Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. — FEI 3002807242

The FDA completed an inspection of Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. on November 21, 2024 in Aprilia. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 21, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Aprilia (Italy)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
891221 CFR 314.81(b)(2)Timely submission